Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Raysearch Laboratories AB publ Receives FDA 510(k) Clearance for RayStation 3.5

Wednesday, 15 May 2013 05:31am EDT 

Raysearch Laboratories AB publ announced that version 3.5 of RaySearch's RayStation treatment planning system had been released for clinical use. RaySearch has received 510(k) clearance from the FDA for RayStation 3.5 meaning that the new features can be marketed in the United States. The new features include Proton Beam Design, a module that contains tools for treatment planning of double scattered and uniformly scanned protons, such as a clinically approved Pencil Beam dose engine and automatic generation of treat-and-protect beams. 

Related Company News

Company Quote

-0.3 -0.70%
7:45am EDT